During the past decade, Butler Memorial Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 21 clinical trials were completed, i.e. on average, 2100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Butler Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 3 trials sponsored, "C. R. Bard" with 1 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Butler Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Butler Memorial Hospital" are "Recurrent Breast Carcinoma" (3 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "HER2/Neu Positive" (2 trials), "Progesterone Receptor Positive" (2 trials) and "Stage IIA Breast Cancer AJCC v6 and v7" (2 trials). Many other conditions were trialed in "Butler Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Butler Memorial Hospital" are "Drug" (22 trials), "Other" (19 trials), "Biological" (16 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Bevacizumab" (8 trials), "Paclitaxel" (6 trials), "Cisplatin" (4 trials) and "Quality-of-Life Assessment" (4 trials). Other intervention names were less common.

The vast majority of trials in "Butler Memorial Hospital" are 22 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Butler Memorial Hospital". undefined are not yet recruiting, 1 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Butler Memorial Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Butler Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Butler Memorial Hospital has several departments that took part in Clinical trials: "Cancer Center at Clarion Hospital" - 2 trials